progress_bar test

Program	Target	Lead optimization	Pre-clinical	IND enabling	Phase 1
Covid-19 therapeutics antibody
ATBM-36M	Spike/Covid-19
ATBM-14M	Spike/Covid-19
Cancer therapeutics antibody
SLAM7-53	SLAM7/MM
Neobody-101	Undisclosed
Cancer CAR-T therapy
ATBM-CarT1	Undisclosed